Chemical Compound
Olmesartan medoxomil
CAS Registry Number
144689-63-4
Primary Record
Olmesartan medoxomil
- In stock
- 4,119 g
- Purity
- 99.5 %
- CAS
- 144689-63-4
Compound Identifiers & Properties
- CAS
- 144689-63-4
- PubChem CID
- 130881
- SMILES
- CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
- Canonical SMILES
- CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
Names & Synonyms
- Olmesartan medoxomil
- Benicar
- Olmetec
- Olmesartan
- 144689-63-4
- Benevas
- Olsertain
- Olvance
- Votum
- Azor
- votume
- CS-866
- Medoxomil
- Openvas
- Olme
- Benicar;
- Olmesartan medoximil
- Benicar (TN)
- Olmetec (TN)
- Olmesartanmedoxomil
- Medoxomil, Olmesartan
- olmesartan-medoxomil
- Cs 866
- Olmesartan medoxomilo
- BENICAR HCT
- Olmesartan-d4Medoxomil
- 4-tert-Butylbenzhydrol
- 6M97XTV3HD
- Spectrum_001944
- Olmesartan Medoxomil RS
- Olmesartan Medoxomil-d6
- RefChem:55771
- UNII-6M97XTV3HD
- C29H30N6O6
- Olmesartan medoxomil CRS
- Spectrum2_000506
- Spectrum3_001676
- Spectrum4_000740
- Spectrum5_001556
- CS866
- DTXSID9045924
- D07UBG
- Benicar, Olmetec,Olmesartan
- CS-866DM
- CS-866RN
- Olmesartan medoxomil (Standard)
- MFCD00944911
- SCHEMBL16403
- SCHEMBL96150
- BSPBio_003491
- DTXCID7025924
- GTPL591
- KBioGR_001040
- KBioSS_002498
- MLS006010109
- Olmetec; Benicar; CS 866
- NSC-758924
- SPECTRUM1505205
- SPBio_000431
- Olmesartan medoxomil (Benicar)
- UQGKUQLKSCSZGY-UHFFFAOYSA-N
- AC1L2Y71
- CHEMBL1200692
- CHEBI:31932
- ERK5-3P13
- KBio2_002490
- KBio2_005058
- KBio2_007626
- KBio3_002711
- KS-00000IVQ
- AOB3863
- DE-092
- Olmesartan medoxomil (JAN/USAN)
- HMS1922L15
- HMS2089K18
- HMS2093K16
- HMS3651E13
- HMS3715N09
- HMS3743O09
- HMS5079G18
- Olmesartan medoxomil (JP17/USP)
- OLMESARTAN MEDOXOMIL [INN]
- OLMESARTAN MEDOXOMIL [JAN]
- Pharmakon1600-01505205
- Olmesartan medoxomil [USAN:INN:BAN]
- OLMESARTAN MEDOXOMIL [USAN]
- ACN-S002532
- AMY22222
- BCP05214
- EBD35964
- KS-1182
- ZINC4149248
- OLMESARTAN MEDOXOMIL [VANDF]
- Tox21_111445
- BDBM50442892
- CCG-39596
- CID130881
- EBC-12821
- Forest Brand of Olmesartan Medoxomil
- HY-17005R
- MFCD09029392
- MSK158406
- NCGC00095136-01
- NP3203
- NSC758924
- OLMESARTAN MEDOXOMIL [MART.]
- s1604
- Sankyo Brand of Olmesartan Medoxomil
- STL451024
- OLMESARTAN MEDOXOMIL [USP-RS]
- OLMESARTAN MEDOXOMIL [WHO-DD]
- AKOS015894907
- AKOS015914772
- C29-H30-N6-O6
- AC-1601
- AN-1125
- BCP9000555
- CCG-221184
- CID:130881
- CS-0577
- IH57934
- NSC 758924
- Olmesartan medoxomil, >=98% (HPLC)
- RP17784
- SB19327
- NCGC00095136-02
- NCGC00095136-03
- NCGC00095136-09
- AK-72894
- AZOR COMPONENT OLMESARTAN MEDOXOMIL
- BC208264
- BC209016
- BR-72894
- CPD004727564
- HY-17005
- OLMESARTAN MEDOXOMIL [ORANGE BOOK]
- SAM001246634
- SC-17112
- SMR002203616
- OLMESARTAN MEDOXOMIL [EP MONOGRAPH]
- SBI-0206741.P001
- SID:283537508
- TRIBENZOR COMPONENT OLMESARTAN MEDOXOMIL
- AB0012006
- AB1009487
- Berlin-Chemie Brand of Olmesartan Medoxomil
- J689.130F
- LS-181818
- OLMESARTAN MEDOXOMIL [USP MONOGRAPH]
- A4082
- CAS-144689-63-4
- CS-0694888
- FT-0601603
- NS00008255
- O0510
- ST24031498
- SW199650-2
- A11615
- D01204
- EN300-122375
- J10058
- Olmesartan medoxomil for system suitability CRS
- S-1787
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- 144689-78-1
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- AB01275443-01
- AB01275443_02
- AB01275443_03
- BENICAR HCT COMPONENT OLMESARTAN MEDOXOMIL
- 689O634
- A808260
- L001061
- SR-05000001987
- I06-0025
- SR-05000001987-1
- SR-05000001987-2
- BRD-K78485176-001-02-9
- BRD-K78485176-001-03-7
- BRD-K78485176-001-06-0
- BRD-K78485176-001-07-8
- I14-41691
- Q27888058
- D000068557
- Z1541759904
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)Methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-iMidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester
- 1H-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- Olmesartan Medoxomil Working Standard (Secondary Reference Standard)
- Olmesartan medoxomil, European Pharmacopoeia (EP) Reference Standard
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
- (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate
- Olmesartan medoxomil, United States Pharmacopeia (USP) Reference Standard
- Olmesartan medoxomil for system suitability, European Pharmacopoeia (EP) Reference Standard
- Olmesartan Medoxomil, Pharmaceutical Secondary Standard; Certified Reference Material
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-h
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-4-(2-hydroxypr
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)imidazole-4-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl=4-(2-hydroxypropan-2-yl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
- (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenylmethyl}imidazol-5-carboxylate;
- (5-Methyl-2-oxo-1,3-dioxolen-4yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate
- (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate
- 1-[[2 -(1H-Tetrazol-5-yl)-4-biphenylyl]methyl]-2-propyl-4-(1-hydroxy-1-methylethyl)-1H-imidazole-5-carboxylic acid (2-oxo-5-methyl-1,3-dioxole-4-yl)methyl ester
- 1-[2 -(1H-Tetrazol-5-yl)-4-biphenylylmethyl]-2-propyl-4-(1-hydroxy-1-methylethyl)-1H-imidazole-5-carboxylic acid 2-oxo-5-methyl-1,3-dioxol-4-ylmethyl ester
- 1127298-55-8
- 1127298-67-2
- 144689-24-7
- 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, (5-METHYL-2-OXO-1,3- DIOXOL-4-YL)METHYL ESTER
- 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl-1H-Imidazole-5-carboxylic acid, (5-methyl -2-oxo-1,3-dioxol-4-yl) methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylic acid 2-oxo-5-methyl-1,3-dioxol-4-ylmethyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylic acid 5-methyl-2-oxo-1,3-dioxol-4-ylmethyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)[1,1 -biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxole-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imi
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(2-Hydroxypropan-2-yl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)[1,1 -biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 4-(2-Hydroxypropan-2-yl)-2-propyl-1-[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 5-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-IMIDAZOLE-4-CARBOXYLIC ACID 5-METHYL-2-OXO-[1,3]DIOXOL-4-YLMETHYL ESTER
- 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
- 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate-T287346
- 604-433-1
- Olmesartan medoxomil; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester (9CI); 1,3-Dioxole, 1H-imidazole-5-carboxylic acid deriv.; Benicar; CS 866; Olmesartan medoxomil; Olmetec
- Olmesartan medoxomil|4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid-(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- Olmetec; 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1Htetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester